Koda A - Search Results

1

Effect of TYB-2285 on passive cutaneous anaphylaxis in rats.

Watanabe A, Tominaga T, Shutoh H, Hayashi H, Tsuji J, Koda A, Nagai H, Kumazawa Y, Shimada H. Watanabe A, et al. Among authors: koda a. Gen Pharmacol. 1997 Feb;28(2):311-5. doi: 10.1016/s0306-3623(96)00225-x. Gen Pharmacol. 1997. PMID: 9013210

2

Active cutaneous anaphylaxis (ACA) in the mouse ear.

Inagaki N, Miura T, Nagai H, Koda A. Inagaki N, et al. Among authors: koda a. Jpn J Pharmacol. 1992 Jun;59(2):201-8. doi: 10.1254/jjp.59.201. Jpn J Pharmacol. 1992. PMID: 1434116 Free article.

3

Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats.

Inagaki N, Miura T, Daikoku M, Nagai H, Koda A. Inagaki N, et al. Among authors: koda a. Pharmacology. 1989;39(1):19-27. doi: 10.1159/000138567. Pharmacology. 1989. PMID: 2479953

4

Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats.

Inagaki N, Miura T, Nagai H, Koda A. Inagaki N, et al. Among authors: koda a. Jpn J Pharmacol. 1988 Feb;46(2):189-92. doi: 10.1254/jjp.46.189. Jpn J Pharmacol. 1988. PMID: 3379829 Free article.

5

Effect of TYB-2285 on antigen-induced histamine release from mouse bone marrow-derived persisting cells (P-cells) primed with interleukin-3-containing conditioned medium (IL3-CM).

Watanabe A, Tominaga T, Hayashi H, Yanagihara Y, Koda A. Watanabe A, et al. Among authors: koda a. Gen Pharmacol. 1993 Sep;24(5):1207-11. doi: 10.1016/0306-3623(93)90370-d. Gen Pharmacol. 1993. PMID: 7505757

6

Tominaga T, Watanabe A, Tsuji J, Haruki H, Koda A. Tominaga T, et al. Among authors: koda a. Gen Pharmacol. 1995 Mar;26(2):353-6. doi: 10.1016/0306-3623(94)00201-w. Gen Pharmacol. 1995. PMID: 7590086

7

Effect of TYB-2285 on histamine release from human basophils in the presence/absence of IL-3.

Tominaga T, Watanabe A, Hayashi H, Yanagihara Y, Koda A. Tominaga T, et al. Among authors: koda a. Gen Pharmacol. 1993 Mar;24(2):345-8. doi: 10.1016/0306-3623(93)90314-n. Gen Pharmacol. 1993. PMID: 7683300

8

Effects of TYB-2285 on the accumulation of eosinophils in the airway induced by antigen exposure in actively sensitized brown Norway rats.

Tominaga T, Watanabe A, Tsuji J, Koda A, Nagai H, Kumazawa Y, Shimada H. Tominaga T, et al. Among authors: koda a. Gen Pharmacol. 1997 Feb;28(2):301-3. doi: 10.1016/s0306-3623(96)00227-3. Gen Pharmacol. 1997. PMID: 9013208

9

Effect of TYB-2285 on lung anaphylaxis in actively sensitized rats.

Watanabe A, Tominaga T, Shutoh H, Hayashi H, Tsuji J, Koda A, Nagai H, Kumazawa Y, Shimada H. Watanabe A, et al. Among authors: koda a. Gen Pharmacol. 1997 Feb;28(2):305-9. doi: 10.1016/s0306-3623(96)00226-1. Gen Pharmacol. 1997. PMID: 9013209

10

Effect of TYB-2285 on antigen-induced accumulation of eosinophils into the peritoneal cavity of rats sensitized with Ascaris suum extract.

Tominaga T, Watanbe A, Tsuji J, Koda A, Nagai H, Kumazawa Y, Shimada H. Tominaga T, et al. Among authors: koda a. Gen Pharmacol. 1997 Mar;28(3):411-4. doi: 10.1016/s0306-3623(96)00298-4. Gen Pharmacol. 1997. PMID: 9068982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters